JAN STERN REED - 16 Jul 2025 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
Director
Signature
/s/ Lawrence T. Weiss, Attorney in Fact
Issuer symbol
ANGO
Transactions as of
16 Jul 2025
Net transactions value
$0
Form type
4
Filing time
18 Jul 2025, 18:06:13 UTC
Previous filing
05 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
REED JAN STERN Director 14 PLAZA DRIVE, LATHAM /s/ Lawrence T. Weiss, Attorney in Fact 18 Jul 2025 0001124181

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Award $0 +17,675 +20% $0.000000 105,034 16 Jul 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The acquisition of 17,675 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") represents 17,675 restricted stock units granted as regular annual compensation for service as a director of AngioDynamics. The restricted stock units immediately vested at the time of grant.

Remarks:

Exhibit 24.1 - Power of Attorney